Free Trial

AlloVir (ALVR) News Today

AlloVir logo
$9.28 +0.28 (+3.11%)
As of 01/17/2025 04:00 PM Eastern
AlloVir, Inc. stock logo
AlloVir (NASDAQ:ALVR) Trading 8.2% Higher - Here's What Happened
AlloVir (NASDAQ:ALVR) Shares Up 8.2% - Here's Why
AlloVir trading halted, news pending
AlloVir, Inc. stock logo
AlloVir (NASDAQ:ALVR) Hits New 1-Year Low - Should You Sell?
AlloVir (NASDAQ:ALVR) Sets New 12-Month Low - Here's What Happened
AlloVir, Inc. stock logo
AlloVir, Inc. (NASDAQ:ALVR) Short Interest Update
AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 1,690,000 shares, a decline of 12.0% from the November 30th total of 1,920,000 shares. Based on an average daily trading volume, of 354,200 shares, the days-to-cover ratio is presently 4.8 days.
AlloVir Appoints Vikas Sinha as New CEO
AlloVir, Inc. stock logo
Short Interest in AlloVir, Inc. (NASDAQ:ALVR) Increases By 57.4%
AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,920,000 shares, a growth of 57.4% from the November 15th total of 1,220,000 shares. Based on an average trading volume of 321,500 shares, the short-interest ratio is presently 6.0 days.
AlloVir, Inc. stock logo
AlloVir (NASDAQ:ALVR) Trading Down 1.2% - Time to Sell?
AlloVir (NASDAQ:ALVR) Trading Down 1.2% - Time to Sell?
AlloVir, Inc. stock logo
AlloVir, Inc. (NASDAQ:ALVR) Sees Significant Drop in Short Interest
AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) saw a large drop in short interest in October. As of October 31st, there was short interest totalling 3,950,000 shares, a drop of 19.2% from the October 15th total of 4,890,000 shares. Based on an average trading volume of 256,400 shares, the days-to-cover ratio is currently 15.4 days.
AlloVir (NASDAQ:ALVR) Stock, Option Chain
AlloVir and Kalaris Merge to Advance Retinal Therapies
AlloVir to combine with Kalaris Therapeutics in all-stock transaction
Wasatch Small Cap Growth Institutional
Wasatch Small Cap Growth Investor
AlloVir, Inc. stock logo
AlloVir (NASDAQ:ALVR) Shares Up 1%
AlloVir (NASDAQ:ALVR) Stock Price Up 1%
AlloVir, Inc. stock logo
Acadian Asset Management LLC Has $1.20 Million Stake in AlloVir, Inc. (NASDAQ:ALVR)
Acadian Asset Management LLC raised its stake in shares of AlloVir, Inc. (NASDAQ:ALVR - Free Report) by 694.6% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 1,587,451 shares of the company's stock after purchasing an additional 1,387,666 shares during th
AlloVir, Inc. stock logo
AlloVir (NASDAQ:ALVR) Trading Up 3.3%
AlloVir (NASDAQ:ALVR) Shares Up 3.3%
AlloVir, Inc. stock logo
AlloVir, Inc. (NASDAQ:ALVR) Shares Sold by Wasatch Advisors LP
Wasatch Advisors LP reduced its position in AlloVir, Inc. (NASDAQ:ALVR - Free Report) by 40.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,784,623 shares of the company's stock after selling 2,535,248
AlloVir, Inc. stock logo
Q2 2024 EPS Estimates for AlloVir, Inc. (NASDAQ:ALVR) Cut by Analyst
AlloVir, Inc. (NASDAQ:ALVR - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for AlloVir in a report issued on Monday, May 13th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of ($0.04) for the quarter, down from the
ALVR Stock Earnings: AlloVir Misses EPS for Q1 2024
AlloVir, Inc. (ALVR)
AlloVir, Inc. stock logo
Short Interest in AlloVir, Inc. (NASDAQ:ALVR) Rises By 5.7%
AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 6,270,000 shares, a growth of 5.7% from the February 29th total of 5,930,000 shares. Based on an average trading volume of 1,970,000 shares, the short-interest ratio is currently 3.2 days.
ALVR Stock Earnings: AlloVir Misses EPS for Q4 2023
Get AlloVir News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter.

ALVR Media Mentions By Week

ALVR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALVR
News Sentiment

-0.14

0.45

Average
Medical
News Sentiment

ALVR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALVR Articles
This Week

4

2

ALVR Articles
Average Week

Get AlloVir News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners